Australia's most trusted
source of pharma news
Tuesday, 13 January 2026
Tuesday, 13 January 2026
Subscribe
Login
Price cuts savage $588M in PBS revenue
A top earning drug on the PBS which brings in more than half a billion dollars a year is one of two medicines facing a monster price cut from next month.
Where are they going? Leaders exit
Mystery surrounds the next career chapter for a string of senior leaders across Australian pharma. See who's on the move
TODAY
New GM welcomes drug approval
Commitment to innovation in science, one of the reasons he joined the company which has notched a significant win
TODAY
Boss ditched Aussie GM job for this...
After being named Novo's next Australian GM then resigning before even starting the job, leader reveals his next move
12 January
New Year, new pharma on the PBS
A European pharma which opened its doors locally last year has officially landed in the Australian market over the holiday period
12 January
Job moves mark start of 2026
Industry readies for 2026 with a raft of job changes as companies round up the best talent for the year ahead
12 January
TGA kicks off with first-in-class nod
2026 is off to a cracking start with a new registration on the ARTG, the first recombinant replacement therapy for a fatal disease
12 January Approvals Action
Latest Jobs
Senior Brand ManagerBusiness Analyst / Product Owner – Digital Health (EMR)Senior Payroll Officer - 41808-1Site Medical DirectorAssociate Business Development Director - Clinical Research, JapanSenior Technical & Regulatory AssociateCustomer Service SpecialistPharmaceutical Sales Representative13 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (9)
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Specialist - Frenchs Forest
- Pharmaceutical Sales Representative - Sydney
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
- Customer Service Representative - St Leonards
- Sales Manager - Sydney
- Hospital Sales Representative - Melbourne
- Clinical Account Manager - Surry Hills
Clinical & Medical, R&D (3)
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Clinical Account Manager - Surry Hills
Regulatory, Pharmacovigilance & QA (2)
Executive Roles (2)
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (8)
'No deal' drugs face PBAC review
More than a dozen drugs have hit the 'use it or lose it' list reflecting the deepening impasse between companies and the Govt
12 January
Trump nets nine more pharmas
There's been a rush of companies signing up to Trump's Most Favoured Nation policy but what's the fallout for Australia?
23 December
It's a wrap: Top 10 stories of 2025
What caught your attention this year? The most read Pharma in Focus news stories of in 2025
23 December
Should you be nervous about 2026?
A review of 2025 shows the year was a mixed bag of good and bad news with many challenges moving forward into next year
23 December
Obesity funding arrives... with strings
PBAC finally recommends Australia's first obesity drug, and gives advice to Butler should the Minister be keen to fund more
22 December
Who made PBAC's Christmas List?
November Meeting outcomes delivered just days before Christmas. Find out who's won a recommendation... and who hasn't
22 December
Best pharma one-liners of 2025
We have curated the best one-liners of 2025 capturing words of frustration, hope and humour that sum up the year
22 December
Top results for Takeda skin pill
Potential to become a leading oral treatment option for people living with psoriasis and other immune diseases
22 December
TGA ticks updates to big names
A next-gen treatment and improvements in delivery have been listed on the ARTG just before Christmas
22 December Approvals Action
First PBS listings of 2026 go to...
The New Year is just 14 days away and there are 11 drugs lining up to make the Government's January reimbursement list
19 November
Year ends with ANZ jobs shake-up
ICYMI: Another Big Pharma has announced a workforce downsize plus the other most popular stories this week
19 December Your Week in 5 Minutes
Doctored truths hurting pharma
Industry urged to tackle the dangerous escalation in healthcare misinformation thanks to growing reliance on AI and social media
19 December
Going, going, gone: last jobs of '25
While industry winds down before diving into a Summer break, some are still out there snapping up the last jobs of the year
19 December
The swamping of the PBAC in 2025
Hundreds of submissions and thousands of community inputs this year saw the Committee re-evaluate its modus operandi
19 December